Cargando…
Cilostazol Attenuates Ovariectomy-Induced Bone Loss by Inhibiting Osteoclastogenesis
BACKGROUND: Cilostazol has been reported to alleviate the metabolic syndrome induced by increased intracellular adenosine 3’,5’-cyclic monophosphate (cAMP) levels, which is also associated with osteoclast (OC) differentiation. We hypothesized that bone loss might be attenuated via an action on OC by...
Autores principales: | Ke, Ke, Safder, Ali Muhammad, Sul, Ok-Joo, Suh, Jae-Hee, Joe, Yeonsoo, Chung, Hun-Taeg, Choi, Hye-Seon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436362/ https://www.ncbi.nlm.nih.gov/pubmed/25992691 http://dx.doi.org/10.1371/journal.pone.0124869 |
Ejemplares similares
-
Protection against Ovariectomy-Induced Bone Loss by Tranilast
por: Phan, Tien Van, et al.
Publicado: (2014) -
Platinum nanoparticles reduce ovariectomy-induced bone loss by decreasing osteoclastogenesis
por: Kim, Woon-Ki, et al.
Publicado: (2012) -
Monocyte Chemoattractant Protein-1 Deficiency Attenuates Oxidative Stress and Protects against Ovariectomy-Induced Chronic Inflammation in Mice
por: Kim, Woon-Ki, et al.
Publicado: (2013) -
Water Extract of Agastache rugosa Prevents Ovariectomy-Induced Bone Loss by Inhibiting Osteoclastogenesis
por: Jang, Seon-A, et al.
Publicado: (2020) -
Cytisine attenuates bone loss of ovariectomy mouse by preventing RANKL‐induced osteoclastogenesis
por: Qian, Zhi, et al.
Publicado: (2020)